In Defense of Off-label Prescribing-Reply

Affiliations

¹ Department of Pharmaceutical Economics and Policy, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences (MCPHS), Boston.
² Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.

Comment

Tewodros Eguale et al. JAMA Intern Med. 2016.

. 2016 Jun 1;176(6):861-2.

doi: 10.1001/jamainternmed.2016.1406.

¹ Department of Pharmaceutical Economics and Policy, School of Pharmacy, Massachusetts College of Pharmacy and Health Sciences (MCPHS), Boston.
² Department of Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Canada.

No abstract available

Comment on

Association of Off-label Drug Use and Adverse Drug Events in an Adult Population.
Eguale T, Buckeridge DL, Verma A, Winslade NE, Benedetti A, Hanley JA, Tamblyn R. Eguale T, et al. JAMA Intern Med. 2016 Jan;176(1):55-63. doi: 10.1001/jamainternmed.2015.6058. JAMA Intern Med. 2016. PMID: 26523731
In Defense of Off-label Prescribing.
Keller DL. Keller DL. JAMA Intern Med. 2016 Jun 1;176(6):861. doi: 10.1001/jamainternmed.2016.1403. JAMA Intern Med. 2016. PMID: 27273485 No abstract available.